Eung-Sam Kim

Title: Innovator Spotlight: Eung-Sam Kim and His Transdermal Delivery System

Introduction: Eung-Sam Kim is an accomplished inventor based in Pohang-si, South Korea. With a focus on innovative drug delivery solutions, Kim has contributed significantly to the field of biotechnology, particularly through his patent on a method for manufacturing transdermally delivered hyaluronic acid-protein conjugates.

Latest Patents: Kim holds a key patent titled "Method for manufacturing transdermally delivered hyaluronic acid-protein conjugate and transdermally delivered hyaluronic acid-protein conjugate manufactured using the same." This innovative patent describes a transdermal delivery system for various protein drugs, including vaccines and chemical drugs. The invention boasts several advantages, including biocompatibility, biodegradability, effective transdermal delivery, enhanced safety for the human body, maximum activity of protein drugs, good bio-conjugation efficiency, and long-term efficacy.

Career Highlights: Eung-Sam Kim's career has been marked by his commitment to enhancing drug delivery systems. His groundbreaking patent reflects his expertise and innovation in the field, positioning him as a leading figure in biotechnology research and development.

Collaborations: Kim has worked alongside notable colleagues such as Sei Kwang Hahn and Jeonga Yang. Their collaborative efforts within Phi Biomed Co., Ltd. have contributed to advancing research and innovations in biomedicine.

Conclusion: Eung-Sam Kim is a visionary inventor whose work is paving the way for safer and more effective drug delivery methods. His patent underscores his dedication to improving healthcare through innovative technologies, making a significant impact in the field of biotechnology.